ROBBINSVILLE, N.J.--(BUSINESS WIRE)--Due to the significant increase in attendance and opportunities for updated business meeting space, the Drug, Chemical & Associated Technologies Association (DCAT) announced it will be expanding its flagship event, DCAT Week (March 20-23, 2017), by introducing four additional venues in Midtown Manhattan. DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries.
Attracting thousands of high-level decision makers annually, DCAT Week has increased its business meeting space block for member companies by 97 percent, and attendance at education programs is up 129 percent. Overall, the organization has experienced a 37 percent increase in total member companies since 2010.
“We are tremendously excited about the growth of our event and the expansion of the DCAT Week neighborhood,” said DCAT Executive Director Margaret Timony. “The different meeting spaces at our eight Official DCAT Week Hotels present us with some fantastic opportunities for new networking events, member lounge space and branding opportunities. But most importantly, we can offer our members updated rooms, amenities and technologies for their important business meetings.”
The 91st DCAT Annual Dinner will be relocated to the ballroom of the New York Hilton Midtown to accommodate more guests in a venue with greater capacity. “It will be fantastic to gather the DCAT community into a single room to celebrate the end of another successful DCAT Week,” said DCAT First Vice President and Annual Dinner Chair Joe Sutton (Eli Lilly and Company). Transportation for guests will also be provided to and from the dinner from all Official DCAT Week Hotels.
To learn more about the exciting new developments for DCAT Week ’17 visit www.dcat.org/DCATWeek.htm and join the conversation at #DCATWEEK.
About DCAT
DCAT is a 501(c)6, not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. www.dcat.org
